Search

everythinglearnresearchcommunity

for

Search:↓

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Females are more likely than males to experience long-COVID symptoms and heart issues.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

Long COVID affects many survivors with ongoing symptoms, needing more research and care.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Antiandrogens don't help with COVID-19 and aren't recommended.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Testosterone's effects on COVID-19 are unclear and need more research.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Certain immune responses may cause ongoing COVID-19 symptoms like fatigue and brain fog.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

About 61% of women who had COVID-19 experienced hair loss afterward.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Thrombophilic conditions may worsen Long COVID symptoms due to increased blood clotting.

Standardized tools and treatments are needed to better manage long COVID-19 in kids and teens.